The company said it received a subpoena March 28 from the U.S. attorney's office in Boston seeking documents relating to standards at its facility in Macclesfield, northwest England. It did not give further details.

AstraZeneca shares fell 1.8 percent to 33.28 pounds on the London Stock Exchange.